Structures by: Miller M. J.
Total: 18
C16H18N2O3
C16H18N2O3
Organic letters (2009) 11, 6 1293-1295
a=27.4692(16)Å b=5.0982(3)Å c=9.8276(6)Å
α=90.00° β=95.032(4)° γ=90.00°
C13H16N6O
C13H16N6O
Organic & biomolecular chemistry (2007) 5, 8 1164-1166
a=5.7926(3)Å b=10.0685(6)Å c=12.2947(7)Å
α=65.8730(10)° β=76.4520(10)° γ=85.5070(10)°
7-Nitro-2-(piperidine-1-carbonyl)-5-(trifluoromethyl)benzo[<i>d</i>]isothiazol-3(2<i>H</i>)-one 1-oxide
C14H12F3N3O5S
Acta Crystallographica Section C (2020) 76, 9
a=17.6719(8)Å b=25.7296(12)Å c=6.8887(3)Å
α=90° β=90° γ=90°
2-[(<i>S</i>)-2-Methyl-1,4-dioxa-8-azaspiro[4.5]decane-8-carbonyl]-7-nitro-5-(trifluoromethyl)benzo[<i>d</i>]isothiazol-3(2<i>H</i>)-one 1-oxide
C17H16F3N3O7S
Acta Crystallographica Section C (2020) 76, 9
a=8.8165(2)Å b=16.1649(4)Å c=13.4246(3)Å
α=90° β=90.0022(12)° γ=90°
C17H16N2O3
C17H16N2O3
The Journal of organic chemistry (2017) 82, 1 737-744
a=7.445(4)Å b=12.465(5)Å c=16.095(6)Å
α=90° β=90° γ=90°
2(C13H15ClN4O3)
2(C13H15ClN4O3)
Journal of Organic Chemistry (2006) 71, 4164-4169
a=6.8927(1)Å b=8.8506(2)Å c=12.6185(3)Å
α=75.920(1)° β=80.014(1)° γ=75.820(1)°
C33H43ClN5O8,H2O
C33H43ClN5O8,H2O
Journal of Organic Chemistry (2006) 71, 4164-4169
a=11.2761(5)Å b=23.5451(9)Å c=26.7168(11)Å
α=90.00° β=90.00° γ=90.00°
C17H22N4O3
C17H22N4O3
Journal of Organic Chemistry (2007) 72, 3929-3932
a=10.7307(15)Å b=18.003(3)Å c=9.4773(14)Å
α=90.00° β=113.798(7)° γ=90.00°
C17H22N4O3
C17H22N4O3
Journal of Organic Chemistry (2007) 72, 3929-3932
a=5.6782(2)Å b=12.3245(4)Å c=12.3822(4)Å
α=108.048(2)° β=102.326(2)° γ=90.219(2)°
C23H26N3O3,C2F3O2
C23H26N3O3,C2F3O2
Journal of Organic Chemistry (2008) 73, 4559-4567
a=9.7374(6)Å b=10.9885(7)Å c=11.9183(8)Å
α=79.199(3)° β=70.316(3)° γ=77.971(3)°
C17H17N5O6
C17H17N5O6
Journal of the American Chemical Society (2013) 135, 3539-3549
a=10.7900(4)Å b=10.1646(4)Å c=16.7717(7)Å
α=90.00° β=105.078(2)° γ=90.00°
C16H18N4O6
C16H18N4O6
Journal of the American Chemical Society (2013) 135, 3539-3549
a=9.66900(10)Å b=8.06660(10)Å c=20.7830(3)Å
α=90.00° β=90.6040(10)° γ=90.00°
N-Benzyl-3,7-dimethylimidazo[1,2-a]pyridine-2-carboxamide
C17H17N3O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=7.9379(3)Å b=19.6844(9)Å c=9.5568(4)Å
α=90.° β=100.934(2)° γ=90.°
N-Benzyl-7-methyl-[1,2,4]triazolo[4,3-a]pyridine-3-carboxamide
C15H14N4O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=9.772(3)Å b=5.8461(19)Å c=22.078(7)Å
α=90.° β=91.411(6)° γ=90.°
N-Benzyl-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide
C15H15N5O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=20.3189(11)Å b=10.8268(5)Å c=15.6023(9)Å
α=90.° β=129.107(3)° γ=90.°
N-Benzyl-6-methyl-2H-indazole-3-carboxamide
C16H15N3O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=5.9164(2)Å b=13.0740(3)Å c=18.5711(5)Å
α=109.4990(10)° β=93.229(2)° γ=94.402(2)°
N-Benzyl-2,6-dimethyl-1H-indole-3-carboxamide
C18H18N2O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=4.7830(3)Å b=25.5753(15)Å c=11.9469(7)Å
α=90.° β=98.639(3)° γ=90.°
N-Benzyl-2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamide (1)
C17H17N3O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=4.8686(4)Å b=15.1351(13)Å c=19.0283(18)Å
α=94.372(5)° β=93.841(6)° γ=93.639(5)°